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1. Introduction 
Spectroscopy measures and interprets phenomena of absorption, dispersion or emission of 
electromagnetic radiation that occur in atoms, molecules and other chemical species. 
Absorption or emission is related to the energy state changes of the interacting chemical 
species which characterise them, which is why spectroscopy may be used in qualitative and 
quantitative analysis. 
The application of spectroscopy to chemical analysis means considering electromagnetic 
radiation as being made up of discrete particles or quanta called photons which move at the 
speed of light. The energy of the photon is related to the wavelength and the frequency by 
Plank’s constant (h = 6.62 x 10-34 J second) and the speed of light in a vacuum (c = 3 x 108 
m/s) according to the following equation (Skoog et al., 2001): 
E = hǎ = hc/ ǌ 
The interaction of radiation with matter is produced throughout the electromagnetic 
spectrum which ranges from cosmic rays with wavelengths of 10-9 nm to radio waves with 
lengths over 1000 Km. Between both extremes, and from the shortest upwards, can be found 
the following: gamma rays, X-rays, ultraviolet rays (far, mid and near), the visible portion of 
the spectrum, infrared rays and radio microwaves. All radiations are of the same nature and 
travel at the speed of light, being differentiated by the frequency, wavelength and the effects 
they produce on matter (Skoog et al., 2008). 
The Bouguer-Lambert-Beer Law is fundamental in molecular absorption 
spectrophotometry. According to this law, absorbance is directly proportional to the 
trajectory of the radiation through the solution and to the concentration of the sample 
producing the absorption although there are limitations to its application. The Law is only 
applied to monochromatic radiation although it has been demonstrated experimentally that 
the deviations with polychromatic light are unappreciable (Skoog & West, 1984).  
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According to the Bouguer-Lambert-Beer Law: 
A = abc 
when b (trajectory of the radiation) is expressed in cm and c (concentration of the substance) 
in g.L-1, the units of a (absorptivity) are L.g-1.cm-1, or  
A = ǆbc 
when b is expressed in cm and c in mol.L-1, a (absorptivity) is called molar absorptivity and 
it is represented by the symbol ǆ and its units are L.mol-1.cm-1 
The absorption of light (A) = log Po/P ( = Optical density or extinction) 
where: 
Po: Incident radiation  
P: Transmitted radiation  
Absorptivity, a, is A/bc       (= Coefficient of extinction) 
Molar absorptivity, ǆ, is A/bc  (= Coefficient of molar extinction)  
The Bouger-Lambert-Beer Law is fulfilled with limitations in molecular absorption 
spectrophotometry (Skoog et al., 2008). 
In 1927, Werner Heisenberg proposed the principle of uncertainty, which has important and 
widespread implications for instrumental analysis. It is deduced from the principle of 
superposition, which establishes that, when two or more waves cross the same region of 
space, a displacement is produced equal to the sum of the displacements caused by the 
individual waves. This is applied to electromagnetic waves in which the displacements are 
the consequence of an electric field, as well as to various other types of waves in which 
atoms or molecules are displaced. The equation ∆t x ∆E = h, expresses the uncertainty 
principle, signifying that, for finite periods, the measurement of the energy of a particle or 
system of particles (photons, electrons, neutrons, protons) will never be more precise than 
h/∆t, in which h is the Planck´s constant. For this reason, the energy of a particle may be 
known as a zero uncertainty only if it is observed for an infinite period (Skoog et al., 2001). 
In 1953, the Australian Physicist Alan Walsh laid the foundations and demonstrated that 
atomic absorption spectrophotometry could be used as a procedure of analysis in the 
laboratory (Willard et al., 1991). The theoretical background on which most of the work in 
this field was based is due almost entirely to this author (Elwell & Gidley, 1966). 
1.1 Fundamentals  
The spectra of atomic absorption of an element are made up of a series of lines of resonance 
from the fundamental state to different excited states. The transition between the 
fundamental state and the first excited state is known as the first line of resonance, being 
that of greatest absorption, and is the one used for analysis. 
The wavelength of the first line of resonance of all metals and some metaloids is greater tan 
200 nm, while for most non-metals it is lower than 185 nm. The analysis for these cases 
requires modifications of the optical systems which increases the cost of atomic absorption 
instruments.  
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In atomic absorption spectrometry, no ordinary monochromator can give such a narrow 
band of radiation as the width of the peak of the line of atomic absorption. In these 
conditions the Beer Law is not followed and the sensitivity of the method is reduced. Walsh 
demonstrated that a hollow-cathode, made of the same material as the analyte, emits 
narrower lines than the corresponding lines of atomic absorption of the atoms of the analyte 
in flame, this being the base of the instruments of atomic absorption. The main disadvantage 
is the need for a different lamp source for each element to be analysed, but no alternative to 
this procedure improves the results obtained with individual lamps. 
The energy source most frequently used in atomic absorption spectroscopy is the hollow-
cathode lamp.  
1.2 Types 
The field of atomic absorption spectroscopy (AAS) includes: flame (FAAS) and 
electrothermal (EAAS or ETAAS) atomic absorption spectroscopy (Skoog et al., 2008). The 
base is the same in both cases: the energy put into the free atoms of the analyte makes its 
electrons change from their fundamental state to the excited state, the resulting absorbed 
radiation being detected. However the fundamental characteristic of the FAAS is the stage 
of atomization which is performed in the flame and which converts the analyte into free 
atoms, whereas in the EAAS the stage of atomization goes through successive phases of 
drying, calcination and carbonization, and it is not required to dissolve the sample in the 
convenient matrix as occurs with the FAAS (Skoog et al., 2008; Vercruysse, 1984).  
1.2.1 Flame atomic absorption spectroscopy  
Prior steps to the stage of atomization in flame are the treatment of the sample, dissolving it 
in a convenient matrix, and the stage of pneumatic nebulisation. In FAAS the stage of 
atomization is performed in flame. The temperature of the flame is determined by the 
fuel/oxidant coefficient. The optimum temperatures depend on the excitation and 
ionization potentials of the analyte. 
The concentration of excited and non-excited atoms in the flame is determined by the 
fuel/oxidant coefficient and varies in the different regions of the flame (Willard et al., 1991). 
1.2.2 Electrothermal atomic absorption spectroscopy  
The electrothermal atomic absorption spectrophotometer has three part: the atomizing head, 
the power source and the controls for feeding in the inert gas. The atomizing head replaces 
the nebulising-burning part of the FAAS. The power source supplies the work current at the 
correct voltage of the atomizing head. The computer control of the atomizing chamber 
ensures reproducibility in the heating conditions, establishing a suitable profile of 
temperatures in the heating scale from environmental temperature to that of atomization so 
that the successive stages of drying, calcination and carbonization the sample must go 
through are those required. The working temperature and the duration of each stage of the 
electrothermal process must be carefully selected taking into account the nature of the 
analyte and the composition of the matrix of the sample. The control unit which measures 
and controls the flow of an inert gas within the atomizing head is designed to avoid the 
destruction of the graphite at high temperatures due to oxidation with the air. 
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One variant of the graphite oven is the carbon bar atomizer. 
The main advantages of electrothermal atomic absorption are:  
a. high sensitivity (absolute quantity of analyte of 10-8 to 10-11 g);  
b. small volumes of liquid samples (5–100 ǍL);  
c. the possibility of analysing solid samples directly without pretreatment and,  
d. low noise level of the oven (Willard et al., 1991). 
2. Applications of atomic absorption spectroscopy in medicine  
Atomic absorption spectroscopy is a sensitive means for the quantification of some 70 
elements and is of use in the analysis of biological samples (Skoog & West, 1984). FAAS 
allows the detection of Ag, Al, Au, Cd, Cu, Hg, Pb, Te, Sb and Sn with great sensitivity 
(Taylor et al., 2002). For most elements, the EAAS has lower detection limits than the FAAS. 
The incorporation of the new technology in the Laboratory of Clinical Biochemistry opened 
the possibility of approaches which had been unthinkable until then. For many of them it 
meant a reinforcement in the central position they held in hospital research. For those which 
incorporated spectroscopy it meant the possibility of new diagnostic, therapeutic and toxic 
controls.  
In this chapter, a series of research studies are presented as example of the above 
mentioned. Thus, with respect to the Sr, refer to section 2.1, the first paper deals with the 
discrimination factor between Ca/Sr in absorption intestinal mechanisms. Afterwards, the 
different behavior of these metals in the binding to serum proteins is studied. And finally, 
the possibility of a hormonal regulation mechanism of serum levels of this element is 
evaluated, given the similarity of its biological behavior with the Ca. 
The quantification of element bound to protein derived towards the direct applications for 
the study of medical problems such as the distribution of Zn in the acute and chronic 
overload and de Zn and Cu in the serum proteins in myocardial infarction.  
Later, in section 2.2, a specific problem resulting from industrial development among other 
causes, threatening a part of the population –Pb poisoning– was tackled, analysing the 
serum and urine concentration of Pb and the hem biomarkers. This example is particularly 
useful not only because of what the technology meant for the diagnosis and control of this 
disorder but also because it has allowed to observe how the levels of this element in our city 
and, in general, in the West has declined over the years. 
Finally, in section 2.3, an actual research is included: the design of a new strategy or 
approach possibility in the knowledge of the physiopathology of different neurological 
conditions based on the concentration of certain trace elements in the CSF, as well as of 
other parameters such as the cellularity, the proteins concentration, etc. 
2.1 Strontium 
This first group of papers serves as a model to analyze how this new technique allows 
evolving from the specific research problems (intestinal absorption, transport of element 
bound to proteins, etc.) to applications in medical pathology, such as the binding of Zn and 
Cu to plasma proteins after myocardial infarction. 
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2.1.1 Introduction  
The disintegration of uranium and plutonium atoms in atomic explosions provokes the 
appearance of a series of elements with maxima in atomic weight of around 90 and 140. The 
isotopes of heavier atomic weight (140) fall in the area of the explosion while those of lower 
atomic weight (90) enter the troposphere and stratosphere. The particles which enter the 
troposphere spread out forming a gigantic belt around the area and are later deposited in 
local rain. Those others which reach the higher zones – the stratosphere – can be 
disseminated in over wide areas. 
Atmospheric and tropospheric precipitation follow more or less quickly but the 
contaminants in the stratosphere may take many years before falling into the troposphere 
and being deposited in zones of greater rainfall. 
Among the elements thrown into the troposphere and stratosphere are found those of the 
first peak of atomic weight (about 90), with two of the artificial isotopes of Sr, 89Sr and 90Sr, 
with different half lives. In particular, the half life of 90Sr is 28.79 years. 
The Sr deposited by the rain together with the Sr present in nature is absorbed by plants 
through the roots and that which is deposited on the leaves may also be absorbed. From 
here it enters the human organism, either directly by consuming the plants or, indirectly, by 
eating the animals which have eaten them. 
Once the Sr has entered the organism it is carried in the blood to the cartilage and bone, 
choice sites for bonding. Far lower rates are found in other tissues. 
In face of this threat, the analyses of animal milk for human consumption as markers of 
radioactive contamination and strategies to prevent the uptake (intestinal absorption) or to 
facilitate the elimination of 90Sr from the bone once it has bonded are priority research into 
Sr domain (Escanero, 1974). 
2.1.2 Development 
2.1.2.1 A curiosity in biological barriers: discrimination between strontium and calcium 
It is assumed axiomatically that biological organisms use Sr less effectively than Ca, which 
means that they discriminate against Sr in favour of Ca. This may be expressed in another 
manner by the concept “Strontium-Calcium Observed Ratio” (OR), the value of which is 
lower than 1. Comar et al. (1956) introduced the term to denote the overall discrimination 
observed in the movement of the two elements from one phase to another under steady-
state conditions. The term OR denotes the comparative rates of Sr and Ca in balance 
between a sample and its precursor and is defined as:  
OR= (Sr/Ca) sample/(Sr/Ca) precursor. 
More precisely, the OR can be defined as the product of a number of 'discrimination factors' 
(DF), each of which is a measure of the extent to which the physiological process to which it 
refers contributes to the overall discrimination. 
In this line it is shown one of the first studies which aimed to ascertain at what intestinal level 
the Sr/Ca discrimination takes place. Vitamin D3, 25-hydroxy-cholecalciferol (25-0H-CC) and 
1,25-dihydroxy-cholecalciferol (1,25 (OH)2-CC) were administered to rats. The apparent and 
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real intestinal absorption were analysed at those moments when their activity was maximum. 
Different concentrations of Sr were used and it was concluded that the discrimination occurred 
in the passive rather than in the vitamin-dependent transport (Escanero et al., 1976). 
2.1.2.2 Hormonal regulation of strontium  
From a general point of view, this research with Sr was designed to find the hormonal 
regulatory mechanisms in order to be able to act on them, provoking or forcing its 
elimination. This approach was based on several facts: a) The chemical similarity between 
Ca and Sr and their common participation in certain physiological processes lead one to 
think that both elements share a hormonal regulatory mechanism; b) The contribution of 
Chausmer et al. (1965) who had demonstrated the existence of specific action of calcitonin 
(CT) on the distribution of Zn, contrary to that exercised in the distribution of Ca, reducing 
the levels of this element in different tissues -thymus, testicles- seemed guiding; and c) 
Comar’s idea (1967) that the plasmatic levels of Ca could participate in the regulation of Sr 
metabolism was particularly attractive. Taking these facts into account and with the 
possibility of a shared hormonal regulation for different trace elements (Zn and Sr among 
others), with specific properties for each one, the first steps in this approach were addressed 
to finding out more about serum Sr. 
In the first study (Escanero, 1974), Comar’s idea was proved since, at the same time as the 
concentration of Sr in bovine blood increased, so did that of Ca in total proteins, the contrary 
phenomena occurring with inorganic phosphorus and Ca in albumin. 
In a later study (Alda & Escanero, 1985), the association constant and the maximal binding 
capacity for Ca, Mg and Sr to human serum proteins taken as a whole were determined. For 
Sr, a maximal binding capacity of 0.128 mmol/g of proteins and the association constant 
(Kprs) of 49.9 ± 16 M-1 were obtained. These values were not far from those of Ca (0.19 
mmol/g of proteins and 55.7 ± 18 M-1).  
Later, Córdova et al. (1990) studied the regulating hormones of Ca and the effects of the 
administration of parathormone (PTH) and CT in rats and after thyroparathyroidectomy 
(TPTX) were analyzed. The PTH excess and defect (TPTX treated with CT + T4) showed 
plasmatic increases in Sr. However, CT excess provokes decreases while the defect 
(administration of PTH + T4 to TPTX rats) causes increases. Consequently, CT may be the 
hormone that plays a regulating role in the plasmatic Sr concentrations.  
In this line, a study (Escanero and Córdova, 1991) was conducted in order to known the 
effect of the administration of glucagon on the serum levels of the alkaline earth metals since 
the phosphocalcic response to glucagon was already known in different animal species and 
it had been reported that, in mammals, glucagon triggered the release of CT by the thyroid 
gland. The study was completed with the analysis of the changes induced in these metals by 
the administration of CT. The effect (reduction) was observed two hours after 
administration and in daily administration the effect peaks on the 3rd day and CT 
significantly reduces the serum levels of these metals up to the 3rd day of treatment, just 
when the glucagon effect is highest. 
2.1.2.3 Continuing with serum proteins 
While the alkaline metals hardly bond in proteins and the alkaline earth metals do so in a 
proportion of 50% or slightly less, the trace elements do so almost completely. Zinc is 
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deposited in a proportion of more than 99% and the proteins involved with albumin and the 
alpha2 macroglobulin (ǂ2MG). The α2MG bound tightly to the metal is responsible for 30-
40%. The aminoacids are only responsible for about 2% of bonded Zn (Giroux & Henkin, 
1972). The serum levels of Zn vary in different pathological symptomatologies and in 
relation to the amount of exercise. Several studies have shown these variations are related to 
the percentage of the element bound to albumin and another one established this relation 
between total serum Zn and ǂ2MG-bound Zn, in athletes after exercise (Castellano et al., 
1988). This last study was aimed at analysing the variations in the serum levels of Zn after 
acute and chronic overload of this element and verifying whether these variations may be 
correlated to changes in the percentage of the element bound to albumin, ǂ2MG or both. 
After a single intragastric administration of 0.5 mL of a solution containing 1000 ppm of Zn, 
the levels of this metal increased significantly (p<0.01) in serum 30 min after the beginning 
of the experiment, reaching maximum values at one hour and returning to normal levels 24 
h later. It should be noted, however, that 8 h after administration the increases were no 
significant (p>0.05). The concentration of Zn bonded to albumin varied in parallel to the 
total serum levels of Zn. The values of bonded Zn in the globulins α2MG also varied but the 
values returned to basal concentrations 4 h after the beginning of the experiment. 
The chronic overload was performed with different groups who underwent a daily 
intragastric dosis of 0.5 mL of the same solution used for the acute overload. Different group 
of animals were sacrificed on days 7, 14, and 30 after the beginning of the experiment, with 
the aim of collecting values at different times of the overload. The control group and one 
other were used for recuperation and were kept for ten days with no treatment after day 30. 
Chronic overload of Zn caused significant increases in the serum levels of Zn throughout all 
the experiments. The highest values were found on the 14th day. The amount of Zn bonded 
to albumin varied in parallel with the total serum Zn; however, the concentrations of Zn 
bonded to globulins (ǂ2MG) showed a significant decrease (p<0.05) on the seventh day, 
increasing significantly (p<0.01) on the 14th day and the 30th day and returning to normal 
values 10 days after Zn overload was interrupted. 
The results of the acute overload suggest a correlation with the proportion of element 
bonded to the albumin and those of the chronic overload showed a rapid response of the 
albumin while the increases of element bonded to the ǂ2MG responded slowly and 
remained constant until the end of the experiment. However, at this time the total serum Zn 
and the Zn bonded to albumin decreased. 
These results suggest that albumin may play a new physiological role by adjusting its 
binding capacity to the serum Zn levels. 
In the same line the levels and distribution of serum Cu and Zn were studied in patients 
diagnosed with acute myocardial infarction from the day of admission to the 
Cardiovascular Intensive Care Unit until the 10th day following the attack (Gómez et al., 
2000). The results obtained showed that Cu increased significantly after the 5th day after the 
myocardial infarction, while Zn decreased significantly (p<0.01) with relation to the control 
group after the 1st day, the lowest values being found on the 3rd day after the attack. 
Later, the total serum Cu showed an excellent correlation with the Cu bonded to the 
albumin and to the globulins (ceruloplasmin), as well as with the concentration of both 
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fractions of serum proteins. In contrast, the total serum Zn only presented this correlation 
with the Zn bonded to the albumin, but not with the Zn bonded to the globulin or the 
albumin concentration. 
These findings suggest the existence of some kind of relationship between the two fractions 
of the element bonded to proteins, which is probably different for each metal. 
A further step was taken when wanting to analyse the possible role of albumin in the uptake 
of Zn by erythrocytes (Gálvez et al., 2001). Zinc is incorporated to erythrocytes by several 
mechanisms: i) passive transport, ii) anionic exchanger, iii) amino acid transport and iv) 
especially in the efflux, the Zn2+-Ca2+ exchanger. In accordance with the free-ligand 
hypothesis only the free fraction could be used for the erythrocyte uptake. The results 
showed a significantly higher uptake (p<0.01) of Zn in the absence than in the presence of 
albumin for equimolar concentrations in both cases. However, the uptake of Zn in an 
albumin-free medium with a similar free-Zn concentration to Zn ultrafiltrable (20%) to 
another with albumin, a significantly (p<0.01) greater Zn uptake was observed in the latter. 
The DIDS (4-4´-diidothiocyanatostilbene-2.2´-disulphonic acid), that inhibits an important 
fraction of the Zn bonded to the anion carrier, also triggered a greater inhibition in the 
uptake of Zn when the albumin was present. Consequently, it was suggested that albumin 
must be directly or indirectly involved in Zn capture, facilitating the processes of passive 
transport and anionic exchanger. 
Other properties of the uptake of Zn by erythrocytes were published in previous reports 
(Galvez et al., 1992, 1996a, 1996b): 
- high dependence on temperature (Zn uptake was almost eliminated at 4º C)  
- dependence on the concentrations of external Na+ and K+ and 
- the apparent dissociation constant for the fast uptake step (15 minutes) is 0.46 ǍM for a 
medium without albumin and 0.121 ǍM with human albumin. For physiological 
concentrations of Zn the value was 15,3 ǍM (unpublished data). 
2.2 Study of the effects of lead in hem biosynthesis  
These studies are shown as an example of integration of the analysis provided for Pb by 
FAAS and EAAS with the results of the biomarkers of hem obtained with other laboratory 
techniques. 
2.2.1 Introduction 
Lead produces interferences in the hem biosynthesis pathway (Cambell et al., 1977), 
inhibiting the enzymatic effects of ALA-Dehydratase (ALA-D, EC 4.2.1.24) in cytosol and 
coproporphyrinogen oxydase (EC 1.3.3.3) and ferrochelatase (EC 4.99.1.1), both in 
mitochondria (González-López, 1992). 
In the exposed organism, Pb produces affection of the target organs and critical effects 
which are characteristic of the disease known as saturnism since the days of Ancient Rome. 
Lead poisoning is diagnosed in the clinic and is shown by the analysis of Pb in blood. 
However, the concentration of Pb in blood depends on the metabolic condition of the 
individual (pH of the internal medium, bone activity, etc.) as well as on interactions with 
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other metals such as Ca, Fe, Zn, Cu and Mg, among others. In order to ascertain the intensity 
and degree of affection of the Pb intoxication, it is necessary the study the so-called 
biomarkers of Pb exposure and poisoning. The most frequently analysed are the enzyme 
ALA-D in erythrocytes, protoporphyrin IX in erythrocytes, 5-aminolevulinic acid (5-ALA) in 
urine and the coproporphyrins in urine (Meredith et al., 1979). 
The extreme sensitivity of ALA-D to divalent Pb ions has resulted in the measurement of its 
activity, as an indirect measurement of Pb in human blood (Berlin et al., 1977). Of all the 
enzymes involved in the hem biosynthesis pathway, it is the one which has been most 
studied due to the inhibiting effect that Pb has on its activity and the practical importance of 
the measurement of the enzymatic activity of ALA-D is considered to be of interest as a 
bioanalytic marker of environmental exposure to Pb. This has been assisted by the 
development of a method which has been standardised at the proposal of the executive 
council of the European Union. Hemberg & Nikkanen (1972) have published an extensive 
report on the biological meaning of ALA-D inhibition and its use as an exposure test. 
As well as because of the effect of Pb, the activity of ALA-D may be also reduced by the 
effect of ethanol in alcoholics and by carbon monoxide in smokers although, in both cases, 
the reduction of activity is slight. In this line, porphyria of Doss is a recessive autonomous 
hereditary disease produced by the alteration of the gen which codifies the synthesis of 
ALA-D located in allele q34 of chromosome 9. It is a rarely presented porphyria, 
characterised by a deficit of ALA-D. In the homozygote form, a great reduction of ALA-D 
activity is observed in erythrocytes (2% of the control mean value), while in the 
heterozygotes, the enzymatic activity of ALA-D is reduced to 50%, being asymptomatic but 
especially sensitive to the toxic effect of Pb even with scarcely increased levels of Pb. The 
improvement of environmental and working conditions as well as the use of unleaded 
petrol, has led to the reduction of the concentration of Pb in blood in the population, a 
phenomenon observed over the last twenty years (González-López, 1992). 
Taking into account the precedent facts, this section will analyse the effects of Pb poisoning 
in the biomarkers of hem studied in order to evaluate the recovery in the post-treatment 
with CaNa2EDTA as chelating agent.  
2.2.2 Development: Subjects and methods 
Subjects: The study of the biomarkers of Pb poisoning was performed in 377 adults (30-65 
years old) and in 36 healthy children aged between 6 and 14. The adults were distributed as 
follows: 325 healthy (control group) and 52 cases of Pb poisoning: 24 severe, 15 slight and 13 
treated with chelating agents. The children were another control group. 
For inclusion in the group of healthy people, control groups, were required to: 
a. No symptoms of lead poisoning and other diseases, 
b. No changes in routine biochemical parameters and 
c. Normal values of biomarkers characteristic of lead poisoning. 
The group of the 13 patients treated with chelating agents were integrated as patients with 
severe poisoning and they were treated with CaNa2-EDTA at doses of 50-75 mg/Kg body 
weight per day for five days, not exceeding the amount of 500 mg. It may be given an 
additional set after two days of interruption. This treatment requires hospitalization and 
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clinical management with special attention to controlling renal function due to its 
nephrotoxicity. 
Methods: The parameters analyzed were: Pb in blood and urine and the biomarkers of hem 
characteristic of Pb poisoning, ALA-D and protoporphyrin IX in blood and 5-ALA and 
coproporphyrins in urine. 
The methods used were as follows: 
Lead was analyzed in heparinized whole blood and 24-hour urine collection in container 
without additives. The first results of Pb were performed in both blood and urine by FAAS, 
using a modification of the method of Hessel (1968) by extraction into n-butyl acetate of the 
complex formed by the Pb with dithiocarbamate ammonium pyrrolidine (Pb-APDC). 
Subsequently, the latest determinations were obtained by EAAS with Zeeman correction 
spectrometry, given the recent introduction of this technique to the laboratory. Blood was 
used diluted to 0.2% nitric acid (Pearson & Slavin, 1993). 
Biomarkers: ALA-D of erythrocytes (in total blood with heparine) was determined applying 
the method of the European Standards Committee (Sibar Diagnostici) (Berlin & Schaller, 
1974; Schaller & Berlin, 1984). 
Erythrocyte-free Protoporphyrin IX (in total blood with heparine) was performed applying 
the method of Piomelli (1977), (Sibar Diagnostici). 
At present, both products are manufactured by Immuno Pharmacology Research (IPR) 
Diagnostics. 
ALA/PBG in urine was determined by means of column chromatography. For analysis a 
modification of the method of Mauzerall & Granick (1956), manufactured by Bio-Rad, was 
applied. 
Determination of porhyrins in urine was performed after the separation of uro- and 
coproporphyrins by means of ethyl acetate which extracts the coproporphyrins from the 
aqueous phase and later absorption of uroporphyrins from the aqueous phase with 
activated Al2O3. Finally, the uroporphyrins are extracted from the Al2O3 activated and the 
coproporphyrins from the ethyl acetate by means of HCl 1.5 N, performing a fluorimetric 
reading of the extracts obtained (Schwartz et al., 1960). 
In cases of the increased excretion of porphyrins, it is important to analyze the porphyrin 
biosynthesis pathway, applying the following analytic methods:  
Analysis of carboxylic acids of free porphyrins in urine, by means of HPLC/FD. The 
chemical structure of the porphyrins presents the natural property of being fluorescent 
compounds, which makes them detectable by spectrofluorimetry. 
The application of high pressure liquid chromatography (HPLC), constitutes a valuable 
resource in research applied to the study of the porphyrin biosynthesis pathway. 
The analysis of the carboxylic acids of free porphyrins does not require any prior treatment 
of the samples (urine or faeces) to be chromatographed. They are only passed through a 22 
Ǎm Millex-GS (Millipore) filter. If the quantity of porphyrins contained in the sample is very 
high, it will be diluted with the eluyent. 
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The method used allows us to obtain a type of chromatogram in which the separation can be 
observed and the identification performed of the carboxylic acids of free porphyrins, from 
the octacarboxylic porphyrins (8-COOH, uroporphyrins) followed by the heptacarboxylic 
porphyrins (7-COOH), hexacarboxylic (6-COOH) and pentacarboxylic (5-COOH) and the 
tetracarboxylic porphyrins (4-COOH, coproporphyrins). The dicarboxylic form (2-COOH, 
protoporfirin) is not excreted in urine (Meyer et al., 1980a; Meyer, 1985). 
As standard the Porphyrin acids chromatographic marker kit is used (Porphyrin products, 
INC., CMK-IA). 
Analysis of type I and II isomers of uroporphyrins and coproporphyrins in urine by means 
of HPLC/FD. According to the disposition the substitutes may adopt around the tetrapyrrol 
ring of the porphyrin molecule, there are only four possible types of uroporphyrinogens (I, 
II, III and IV), but in nature only the type I and III uroporphyrinogens exist and, 
consequently, decarboxylation will only produce coproporphyrinogens I and III. 
The use of high pressure liquid chromatography (HPLC) with fluorimetric detection (FD) 
allows to separate and identify the isomer forms of type I and III uro- and coproporphyrins 
as metabolytes derived from the oxidation of the corresponding porphyrinogens, produced 
in the process of natural metaloporphyrin biosynthesis. With this aim, the application 
method described by Jacob et al. (1985) was used. 
With this method, a chromotagram is obtained in which the separation and identification 
can be observed of the isomers of uroporphyrins I and III and coproporphyrins I and III 
which are eluated and detected in this order. 
The following standards are used: Uroporphyrin fluorescence standard, Uroporphyrin I 
(Porphyrin products, INC. UFS-I), Uroporphyrin III octamethyl ester (Sigma), 
Coproporphyrin I (Sigma), Coproporphyrin fluorescence standard, Coproporphyrin III 
(Porphyrin products, INC. CFS-3). 
Analysis of protoporphyrin-Zn of erythrocytes in blood.  
The alteration of the enzymatic activity of ferrochelatase due to the inhibition of this enzyme 
by the effect of Pb produces an increase in the protoporphyrin IX concentration in 
erythrocytes. This increase of protoporphyrin IX produces and accumulation of Zn-
protoporphyrin I due to the complexation formation of this porphyrin with Zn2+. 
The method described by Meyer et al. (1980) was used for the analysis of porphyrins in 
erythrocytes. They developed a procedure for the separation of porphyrins from erythrocytes 
in blood with HPLC/FD in reverse phase by formation of the ionic pair (Meyer et al., 1982).  
The standards used were Coproporphyrin fluorescente Standard (Porphyrin products, INC. 
CFS-3, Logan, UTA, USA), Protoporphyrin fluorescent Standard (Porphyrin products, INC. 
PFS-9, Logan, UTA, USA) and Mesoporphyrin IX (Porphyrin products, INC. M 566-9, 
Logan, UTA, USA). 
2.2.3 Development: Results 
The first group of values (results not published) were obtained in an early study and show 
the concentrations of Pb in blood and urine, as well as the values of various biomarkers of 
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the porphyrin biosynthesis pathway. Moreover, it was also included the results of a second 
study from some years later, presenting the normality values of Pb in blood as an update, 
observing the difference of Pb concentration with respect to the earlier study. 
I.A Control group. The results of the control group for Pb in blood and in 24 hours urine are 
shown in Table I. In Table 2 are presented the values of ALA-D and protoporphyrin IX in 
erythrocytes for the same population and in Table III those of the hemoglobin concentration 
and protoporphirin IX/g of haemoglobin coefficient. In table 4 are indicated the values of 5-
ALA and porphobilinogen (PBG) in 24 hours urine and in the last (table 5) are presented the 
results found in urine of 24h of uroporphyrins and coproporphyrins. 
 
 Pb in blood Pb in 24 hours urine 
 µg/dL µg/dL 
 x ± SD x ± SD 
Men (n = 104) 17.72 ± 6.01 45.10 ± 39.85 
Women (n = 61) 14.00 ± 3.86 35.78 ± 27.26 
Adults (n = 165) 16.54 ± 5.49 40.96 ± 35.01 
Children (n = 36) 14.58 ± 2.79 - 
Table 1. Values (x ± SD) of Pb in blood and in 24 hours urine  
 
 ALA-D Protoporphyrin IX 
 U. of CEE/mL erythrocytes* µg/dL of blood 
 x ± SD x ± SD 
Men (n = 104) 44.70 ± 13.94 28.92 ± 11.50 
Women (n = 61) 50.41 ± 17.27 26.80 ± 9.66 
Adults (n = 165) 46.81 ± 15.45 28.13 ± 10.87 
Children (n = 36) 64.42 ± 13.39 28.53 ± 9.28 
(*): Units of the European Standards Committee 
Table 2. Values (x ± SD) of ALA-D and protoporphyrine IX in erythrocytes 
 
 Hemoglobin Protoporphyrin IX 
 g/dL of blood µg/g Hb 
 x ± SD x ± SD 
Men (n = 104) 15.27 ± 1.54 1.92 ± 0.84 
Women (n = 61) 13.39 ± 1.16 2.02 ± 0.78 
Adults (n = 165) 14.57 ± 1.68 1.96 ± 0.82 
Children (n = 36) 12.94 ± 0.71 2.19 ± 0.65 
Table 3. Values of Hb in blood and protoporphyrin IX/g of Hb coefficient 
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 5-ALA PBG 
 mg/24 hours mg/24 hours 
 x ± SD x ± SD 
Men (n = 223) 2.96 ± 1.30 0.41 ± 0.42 
Women (n = 102) 2.42 ± 1.17 0.35 ± 0.35 
Adults (n = 325) 2.79 ± 1.28 0.39 ± 0.40 
Children (n = 36) 2.84 ± 0.91 0.46 ± 0.43 
Table 4. Normal values of 5-ALA and PBG in urine of 24 hours 
 
 Uroporphyrins Coproporphyrins 
 μg/24 hours μg/24 hours 
 x ± SD x ± SD 
Men (n = 223) 11.09 ± 6.00 101.95 ± 55.46 
Women (n = 102) 9.08 ± 4.95 64.34 ± 35.07 
Adults (n = 325) 10.46 ± 5.76 90.15 ± 52.88 
Children (n = 36) 4.18 ± 2.98 56.59 ± 34.03 
Table 5. Normal values of uroporphyrins and coproporphyrins in 24 hours urine  
The values of Pb in blood and urine (Table 1) for the different population groups studied are 
within the range of those reported by other authors of the time the study was conducted 
(Carton, 1985; Carton, 1988). Because of that environmental improvements and labor have 
reduced Pb concentrations in the environment, the serum concentration of Pb have been also 
reduced (Trasobares, 2010). 
With regard to the values of the biomarkers of Pb poisoning in blood analyzed (Tables 2, 3, 4 
and 5), all of them are within the range reported by other authors (Goldberg, 1972; 
Tomokuni, K. & Ogata, 1976; Campbell et al., 1977; Goldberg et al. 1978; Granick et al., 1978; 
Meredith et al. 1979; Sakai et al., 1982; Barbosa et al., 2005). Although the standard deviation 
values can be considered high for some parameters, this should not be attributed to the 
methodology used given the biological variability that is observed in the study population. 
There have also been included the values for Hb in the blood and the ratio of 
protoporphyrin IX/g of Hb. This last value increases in the Pb poisoning (protoporphyrin 
increased and decreased hemoglobin) while in the protoporphyria the Hb did not decrease 
and consequently the ratio does not increase as much as in the Pb poisoning. Likewise the 
values of 5-ALA, PBG and porphyrins (uro-and copro-) are included in the study as they 
provide a more complete picture of potential changes in Pb poisoning. 
I.B Pb poisoning. In table 6 and 7 are presented the statistical tests of comparison of means 
observed in large samples with independent data and their degree of significance, 
performed for each biomarker of Pb poisoning analysed in each group studied with respect 
to the control group. Specifically, in table 6 are presented the results in blood of Pb, ALA-D, 
protoporphyrine IX and Protoporphyrine IX/g Hb and in table 7 the results in urine (24 
hours) of Pb, 5-ALA, PBG, uroporphyrins and coproporphyrins. 
www.intechopen.com
 
Macro to Nano Spectroscopy 
 
16
  BLOOD  
 Pb ALA-D Protoporphyrine IX Protop. IX/Hb 
 μg/dL U/mL μg/dL μg/g Hb 
 x ± SD x ± SD x ± SD x ± SD 
Control group 
(n = 165) 
16.54 ± 5.49 46.81 ± 15.45 28.13 ± 10.87 1.96 ± 0.82 
Severe pois. 101.04±58.03b 12.00 ± 5.56b 198.49 ± 89.51b 17.24 ± 8.74b 
Slight pois. 41.60±15.86b 26.47 ± 20.50b 26.57 ± 92.15b 9.65 ± 7.35b 
Post Treatment 40.92±18.74b 37.08 ± 14.20a 116.94 ± 106.21b 8.70 ± 8.26b 
 
Concentration of Hb (g/dL blood) in each group studied:  
Control group: 14.57±1.68;  
Severe poisoning: 11.46±1.98b  
Slight poisoning: 13.59±1.46a;  
Post treatment: 14.12±1.17 
 
Degree of statistical significance: a (p < 0.050); b (p < 0.001);  
Table 6. Values (x ± SD) of Pb, ALA-D, protoporphyrine IX and Protoporphyrine IX/g Hb in 
blood of the indicated group 
The above table shows that in both, severe and slight Pb poisoning, the increases in the 
concentration of blood Pb are associated with significant inhibition of ALA-D activity 
(Campbell et al., 1977; Goldberg et al., 1978; Sakai et al., 1982) and with significant increases 
of protoporphyrin IX concentrations (Goldberg et al., 1978; Meredith et al., 1979). After 
treatment the values still remain significantly altered, indicating that the patients need a 
new series of treatment, because of the guidelines therapy is performed during five days 
with breaks in which they carry out checks on biomarkers. The fact of treating patients with 
different series of treatment would explain the dispersion of the results. 
 
  URINE   
 Pb 5-ALA PBG UroporphyrinsCoproporphyrins 
 μg/24h mg/24h mg/24h μg/24h μg/24h 
 x ±SD x ±SD x ±SD x ±SD x ±SD 
Control group 
(n = 325) 
41±35 2.79±1.28 0.39±0.60 10.46±5.76 90.15±52.88 
Severe pois. 361±189b 47.3±21.8b 2.21±1.84a 26.4±18.8b 1612.9±682.8b 
Slight pois. 114±81b 4.89±1.96b 0.49±0.62 5.61±2.25 87.7±54.2 
 
Post treatment 197±167b 5.43±3.52b 0.42±0.62 9.67±6.50 148.9±119.1b 
Degree of statistical significance: a (p<0.002); b (p<0.001). 
Table 7. Values (x ±SD) of Pb, 5-ALA, PBG, uroporphyrins and coproporphyrins in 24 hours 
urine 
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The identification and quantification of high levels of porphyrins in erythrocytes, mainly 
protoporphyrin IX and its chelated form, Zn-protoporphyrin, are essentials in the diagnosis 
of Pb poisoning and in erythropoietic porphyrias (Meyer et al., 1980b). 
The results of the above table present significant differences in the Pb urinary elimination in 
Pb poisoning both severe as slight in relation to the control group. Moreover, increases in 
the elimination of all parameters (biomarkers) analyzed in severe poisoning, being the most 
important those of the 5-ALA and coproporphyrins. In contrast, in slight poisoning has only 
significantly increased the elimination of 5-ALA. After treatment of severe cases there is a 
significant decrease in excretion of 5-ALA and coproporphyrins, keeping the levels still 
increased. Of the above comments it can be seen that the most effective urinary biomarkers 
are the urinary elimination of 5-ALA and coproporphyrins (type isomeric III).  
These results agree, in the literature review performed, with the studies published by 
numerous authors and refered in the Doctoral Thesis of González-López (1992) and others 
(Sakai, 2000; Gurer-Orhan et al., 2004). All of them showed the influence of Pb on the heme 
biosynthesis pathway and the effects produced in some of the enzymes which take part in 
the biosynthesis of porphyrins, phenomena demonstrated in clinical research, in vitro 
studies and in experiments on animals. 
In the diagnosis and evolutionary control of Pb poisoning, the study of the biomarkers of 
the hem biosynthesis pathway is very efficient, even more so than that demonstrated by the 
concentration of Pb in blood and urine due to the susceptibility of these to hormonal 
influences as well as metabolic ones such as the pH of the internal medium and the activity 
of bone turnover. According to this, Pb in blood means the degree of uptake; Pb in urine, the 
degree of elimination; Pb in urine provoked by EDTA or some other chelating agent, the 
degree of accumulation; ALA-D, the degree of exposure and is directly related to Pb in 
blood; erythrocyte free protoporphyrin IX, especially Zn-protoporphyrin IX, the degree of 
intake and chronic evolution; and the coproporphyrins (coproporphyrin III) the severity of 
the poisoning. 
II. In the second study was performed a review of the values of Pb in blood in the present. 
The values were obtained by EASS in a graphite furnace with correction of the Zeeman 
effect, in a sample of 156 individuals. The results obtained are shown in Table 8.  
 
 Pb in blood 
 μg/dL 
 x ± SD 
Men (n = 83) 3.51 ± 2.16 
Women (n = 73) 2.29 ± 1.64 
Adults (men + women) (n = 156) 2.94 ± 2.02 
Table 8. Normal values (x ± SD) of healthy individuals of Pb concentration in blood  
These results indicate a decrease of the concentration obtained in 1989 which was 13.17 ± 
3.47 Ǎg/dL, attributed to the improvement of environmental and working conditions as 
well as to the suppression of Pb as antiknock agent in petrol (Izquierdo-Álvarez et al., 1985; 
Trasobares, 2010).  
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In the review of results for 2008 (results not published), the values for ALA-D in the adult 
sample were 60.59 ± 16.49 (x ± SD), higher than those obtained in 1990: 46.81 ± 15.45 (x ± 
SD), which is logical if we take into account the fact that the activity of ALA-D in 
erythrocytes has a negative or inverse correlation with respect to the concentration of Pb in 
blood. In the 1990 study, Pearson’s coefficient of linear correlation obtained was: r = -0.568 
(p<0.001). 
2.3 Study of some elements in cerebrospinal fluid: physiopathological evaluation 
This study, still in progress, can serve as an example of using the atomic absorption 
spectrometry technique for the assistance, together with other techniques, in the clinical 
diagnosis of some diseases. 
2.3.1 Introduction 
The cerebrospinal fluid (CSF) fills the subarachnoid space between the arachnoid 
membranes and the pia mater called leptomeninges which protect the Central Nervous 
System -CNS- (encephalon and spinal cord). Seventy percent of the CSF is formed in 
secretory structures called choroid plexi and the remaining 30% is produced from the 
cerebral capillaries (Carpenter, 1985). 
Although the composition of CSF is similar to a plasma filtrate, there are differences which 
indicate that the CSF formed is produced both by a process of filtration and by active 
secretion, an osmotic balance being observed between CSF and plasma. A similarity can be 
seen in the composition of CSF and the extracellular liquid of the nervous system, indicating 
an easy interchange between both compartments. The CSF and in the cerebral interstice are 
separated from the blood circulation by the hematoencephalic and hematocephalorachideal 
barriers which prevent the free passing of substances. This is why they are considered to be 
functional elements of protection of the nerve cells (Nolte, 1994). In comparison with 
plasma, the CSF contains a greater concentration of Na, Cl and Mg and a lower one of 
glucose, proteins, amino acids, uric acid, K, bicarbonate, Ca and phosphate (Guyton, 1990). 
These differences indicate that the CSF is produced by a mechanism of active secretion and 
varies according to the location of CSF extraction with regard to the structures it bathes. 
Water passes from the stroma to the CSF following the concentration gradient produced by 
the ATPase-dependent carrier proteins, Cl, Ca and Mg (Nolte, 1994). Cellular metabolytes 
also enter the extracellular liquid from neurones and glial cells. 
The CSF maintains an appropriate chemical environment for neurotransmission and 
removes metabolic products and substances which are harmful for the CNS. 
2.3.2 Development 
In this research, it has been studied the concentration of Ca, Mg, Zn, Cu, Fe and Mn in CSF 
in order to analyze their influence on the pathogeny of some neuropathies (González-
Romarís et al., 2011). 
The mineral chemical elements and the trace elements were analysed in the CSF extracted 
from 37 people (17 men and 20 women, between 27 and 73 years of age) who were considered 
to be healthy after performing a clinical and analytical study. They made up the control group. 
www.intechopen.com
 
Atomic Absorption Spectroscopy: Fundamentals and Applications in Medicine 
 
19 
In addition, analysis was made of the CSF of 136 individuals from the Services of Neurology, 
Neurosurgery and Emergency. The CSF was extracted by lumbar puncture in all cases. 
The analysis of Ca, Mg, Zn, Cu, Fe and Mn was performed by flame atomic absorption using 
the corresponding hollow cathode for each metal. The wavelengths for the reading of the 
absorbance corresponding to each cation analysed were the indicated by the manufacturer. 
The values (mean and standard deviation) obtained in the control group for each metal 
analysed were as follows: Ca (mg/dL), 4.95 ± 0.70; Mg (mg/dL), 2.74 ± 0.10; Zn (µg/dL), 
17.40 ± 7.50; Cu (µg/dL), 15.70 ± 4.50; Fe (µg/dL), 13.10 ± 3.60; and Mn (µg/dL), 2.50 ± 0.70. 
These values agree with the findings published by other authors (Hazell, 1997; Kapaki et al., 
1997; Levine et al., 1996). 
With regard to the results obtained in the pathological CSF, significant increases were found 
(p<0.05) in the concentrations of Ca, Cu, Fe, Zn and Mn in the groups classified with cell 
and protein increase in CSF in comparison to the control group. It was also see that the 
significant increase of the Ca, Zn and Cu concentrations is greater in those groups which 
present a higher concentration of proteins, while the increase of Mn corresponds to the 
increase of cell count. With regard to magnesium, it was seen that the significant reduction 
of its concentration in relation to the control group corresponds equally both if the cell count 
or the protein concentration was increased. 
Interest in analysing these metals in CSF is directed to explaining the pathogenesis of some 
dysfunctions of the CNS. Clinical and experimental studies reviewed in the literature 
confirm the influence that these metals have on the pathogeny of some CNS dysfunctions 
and diverse neuropathies. 
In this way the Ca and Mg ions play an important role in the action of glutamate, which is 
one of the most important neurotransmitter of vertebrates in the brain. The receptor of 
glutamate N-methyl-D-aspartate (NMDA) can only be activated in certain conditions of 
depolarisation of the membrane (Johnson & Ascher, 1988). The Mg ion blocks the channel, not 
being permeable to the Ca ions. When the receptor of glutamate are activated, the receptor 
reduces its affinity for Mg and the channel becomes permeable, permitting the entry of Ca ions 
to the neurone, a phenomenon which has been related to memory and the learning process 
(Hammond & Tritsch, 1990; Thomson, 1986). A reduction has been found in the glutamate and 
Mg concentration in the CSF in schizophrenic patients (Levine et al., 1996). 
Some studies have found an increase of Cu in serum and CSF and an increase of Mn in the 
spinal cord in Amyotrophic Lateral Sclerosis (ALS), which suggests that this metal plays a 
role in the pathogeny of this disease (Kapaki et al., 1997). 
The clinical association of Pb poisoning and ALS with an increase of Pb in blood and bone 
has been reported (Kamel et al., 2006). It has been suggested that patients with 
polymorphism in the gene of the ALA-D enzyme might be more at risk of presenting ALS in 
exposure to Pb (Kamel et al., 2003). Other studies have found no association between 
exposure to metals and ALS (McGuire et al., 1997; Bergomi et al., 2002).  
It has been suggested that, regarding Mn, the binding of this metal in the basal ganglions of 
the brain may contribute in the pathogeny of the symptomatology of hepatic 
encephalopathy (Kuliseusky & Puyols, 1992; Weissenborn, 1995; Noremberg, 1998). 
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Moreover, it has been demonstrated that Mn reduces the uptake of glutamate in cultivated 
astrocytes. The great capacity of astrocytes to accumulate Mn suggests that its uptake by 
these cells may play an important role in the development of Alzheimer’s type II 
astrocytosis (Hazell, 1997; Aschner & Gannon, 1992). 
In conclusion, this research line, still in progress, can be highly promising to clarify the 
pathogenesis of some brain conditions. 
3. Conclusions 
After incorporating the atomic absorption spectrophotometry (spectroscopy) to the hospital 
laboratories has been observed that the medical research has improved in these laboratories. 
In this chapter the highlighted technique has been presented through a few research 
examples with different metals. 
The conclusions from the research with the metal studies have been the following: 
a. Strontium:  
- The intestinal absorption discrimination between Ca and Sr takes place in the 
passive transport mechanism and not in the active one or of vitamin D dependent 
mechanism. 
- With respect to the hormonal regulation of the plasmatic Sr, the CT is the only 
hormone that caused consistent changes in the concentrations of this element.  
- The addition of Sr in vitro to equimolar concentrations with Ca to bovine serum 
forces the binding of this last element with the total serum proteins. An opposite 
phenomenon takes place when the experience is conducted with albumin bovine as 
a single protein. 
b. Zinc and Copper:  
- The Zn bound to albumin varies more consistently than Zn bound to globulins 
after acute and chronic overload. This fact allows suggesting that the albumin 
could act as a buffer.  
- In the myocardial infarction, Cu in serum increases significantly after the 5th day 
after the heart attack, while the Zn in serum decreases from the 1st day; being the 
lowest values of Zn found on the 3rd day after the attack. The total Cu in serum 
showed an excellent correlation with the Cu bonded to the albumin and to the 
globulins (ceruloplasmin), while, the total Zn in serum only presents a positive 
correlation with the Zn bonded to the albumin. 
c. Lead: 
- In the diagnosis and the control of the Pb poisoning, the study of the biomarkers of 
the hem biosynthesis pathway is very efficient, even more so than its concentration 
of Pb in blood and urine. 
- According to this, the Pb concentration in blood means the degree of Pb intake; the 
Pb concentration in urine, the degree of its elimination; the Pb concentration in 
urine after the administration of EDTA or some other chelating agent (Dimercaprol 
–BAL, British Anti-Lewisite- and penicilamine), the degree of its accumulation; the 
ALA-D activity, the degree of exposure and these ones are directly related to the 
levels of Pb in blood; the Zn-protoporphyrin IX concentration, the degree of intake 
and chronic poisoning evolution; and finally the coproporphyrins (coproporphyrin 
III) gives an indication of the severity of the poisoning. 
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- In recent years the concentration of Pb in blood has decreased significantly in the 
aragonese population. 
d. Metals in cerebrospinal fluid (Ca, Mg, Zn, Cu, Fe and Mn): 
- The concentration of different metals jointly with the rates of cellular and protein 
concentration has been proved to be a useful tool for the understanding of the 
pathogenesis of some brain conditions.  
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